Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).
暂无分享,去创建一个
E. Antman | R. Giugliano | E. Braunwald | C. McCabe | M. Mercuri | J. Hanyok | C. Ruff | D. Salazar | S. Crugnale | M. Shi | Indravadan Patel | Tomas Bocanegra | Tomas S. Bocanegra